Unimech Aerospace and Manufacturing Ltd, incorporated in the year 2016, has its registered office in 538 539 542,543 7th Main ...

Space and defense company Voyager Technologies said on Tuesday it has confidentially filed for an initial public offering in the United States.

Insulin delivery device maker Beta Bionics said on Wednesday it was targeting a valuation of as much as $615.9 million in its initial public offering in the United States, underscoring a gradual ...

Karman Space, a company that specializes in missile, defense and space manufacturing and design, filed to go public on Tuesday. The company applied to trade on the New York Stock Exchange under the ...

Trading platform eToro has reportedly filed confidentially for a US IPO that could value the company at over $5 billion.

Three SPACs priced this week. Hennessy Capital VII ( HVIIU) raised $175 million to target industrial tech and energy ...

The Edelweiss Recently Listed IPO Fund Regular Plan Growth has an AUM of 973.95 crores & has delivered CAGR of 20.97% in the last 5 years. The fund has an exit load of 2.00% and an expense ratio ...

The IPO of Denta Water and Infra Solutions is entirely a fresh share sale of 75,00,000 equity shares, amounting to Rs 220.50 crore at the upper end of the price band. Stallion India ...

VWAP, or volume-weighted average price, is a technical analysis tool used primarily on intraday charts. It provides a benchmark for the average price a security has traded at during the day ...

10/01/2025 18:35 {New Stock}NEW GONOW RV ends down 18.11% on grey market 10/01/2025 16:20 {New Stock}YIBIN BANK down 2.32% at HK$2.53 on grey market 10/01/2025 16:20 {New Stock}NEW GONOW RV down ...

Laxmi Dental IPO debuted strongly on January 20, listing at ₹542, a 26.64% premium. The stock surged to ₹584, reflecting strong investor interest. Analysts recommend holding shares for long ...

According to a prospectus on the IPO, Zenas ended the second quarter with around $184 million in cash and has earmarked most of the IPO proceeds for obexelimab's clinical trials programme ...